Lost password ?
Gulf Pharmaceutical
Strong profit in H1
- "Gulf Pharmaceuticals delivered H1 revenues perfectly in line with our estimates. Q2 sales jumped by 9.5% and H1 revenues increased by 2.8% to AED883.1m. "
Executive summary
Conflicts of Interest
Pages 38
Language English
Publish on August 21, 2024
€ 500
VAT Exl.
You may also be interested by these reports :
FIND A REPORT
SIMPLE, TO THE POINT IDEA GENERATION
Each company is researched in depth using a structured, robust and transparent process. Valuations are disciplined and dispassionate.
AlphaMena allows you to compare stocks along a wide range of parameters be it by sector, by geography or an array of investment themes.
Our reports include actuarial as well as off balance-sheet data and governance metrics.
Priority is given to idea generation through quick, to the point, answers by means of browsing from one idea to the next.